← Back to Search

Imaging Device for Glaucoma

N/A
Recruiting
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

"This trial is using a device called P200TE to capture images of glaucoma patients."

Who is the study for?
This trial is for adults aged 22 or older with glaucoma, having a visual acuity of 20/40 or better in the study eye. Participants must have had visual field defects consistent with glaucoma within the last year and be able to give informed consent. Those with other eye diseases, poor tolerance for ophthalmic imaging, or unclear ocular media are excluded.
What is being tested?
The P200TE device is being tested to capture images from patients with glaucoma. The goal is to evaluate how well this device works in detecting and assessing changes related to glaucoma by analyzing optic nerve damage through captured images.
What are the potential side effects?
Since the intervention involves non-invasive imaging without medication, there are no direct side effects associated with drugs. However, discomfort due to bright lights during imaging or potential anxiety about testing could occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Imaging DeviceExperimental Treatment1 Intervention
Various scans will be captured
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370

Find a Location

Who is running the clinical trial?

Optos, PLCLead Sponsor
18 Previous Clinical Trials
3,480 Total Patients Enrolled
6 Trials studying Glaucoma
428 Patients Enrolled for Glaucoma
~7 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top